Efficacy and Safety of Irinotecan-Based Chemotherapy for Advanced Colorectal Cancer outside Clinical Trials: An Observational Study

Publisher： Karger

E-ISSN： 2296-5262|33|12|684-690

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.12, 2010-11, pp. : 684-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Cetuximab plus Irinotecan for Oxaliplatin- and Irinotecan-Based Chemotherapy-Refractory Patients with Advanced and/or Metastatic Colorectal Cancer: Evaluation of Efficacy and Safety Based on KRAS Mutation Status (T-CORE0801)

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 7-20

Karger

Access to resources Recommend Favorite

Bevacizumab plus Irinotecan-Based Regimens in the Treatment of Metastatic Colorectal Cancer

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 118-128

Karger

Access to resources Recommend Favorite

First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 353-357

Karger

Access to resources Recommend Favorite

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Efficacy and toxicity of capecitabine-based chemotherapy in patients with metastatic or advanced breast cancer: results from ten randomized trials

By Wang Yongqing   Yang Haiwei   Wei Ji-Fu   Meng Ling  

Current Medical Research and Opinion, Vol. 28, Iss. 12, 2012-12 ,pp. : 1911-1919

Informa Healthcare

Access to resources Recommend Favorite